nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—TUBB—dilated cardiomyopathy	0.47	0.771	CbGaD
Docetaxel—EGFR—dilated cardiomyopathy	0.14	0.229	CbGaD
Docetaxel—ABCC2—Spironolactone—dilated cardiomyopathy	0.0721	0.42	CbGbCtD
Docetaxel—ABCC2—Furosemide—dilated cardiomyopathy	0.0493	0.287	CbGbCtD
Docetaxel—ABCB1—Lisinopril—dilated cardiomyopathy	0.0267	0.156	CbGbCtD
Docetaxel—ABCB1—Spironolactone—dilated cardiomyopathy	0.0235	0.137	CbGbCtD
Docetaxel—Carcinoma breast—Spironolactone—dilated cardiomyopathy	0.0084	0.0946	CcSEcCtD
Docetaxel—Auditory disorder NOS—Furosemide—dilated cardiomyopathy	0.00457	0.0515	CcSEcCtD
Docetaxel—Drug fever—Spironolactone—dilated cardiomyopathy	0.00341	0.0383	CcSEcCtD
Docetaxel—Cabazitaxel—TUBB—dilated cardiomyopathy	0.00312	0.553	CrCbGaD
Docetaxel—Breast cancer—Spironolactone—dilated cardiomyopathy	0.00312	0.0351	CcSEcCtD
Docetaxel—Ototoxicity—Furosemide—dilated cardiomyopathy	0.00308	0.0347	CcSEcCtD
Docetaxel—Paclitaxel—TUBB—dilated cardiomyopathy	0.00252	0.447	CrCbGaD
Docetaxel—Menstruation irregular—Spironolactone—dilated cardiomyopathy	0.00205	0.0231	CcSEcCtD
Docetaxel—MAP4—myocardium—dilated cardiomyopathy	0.00166	0.0578	CbGeAlD
Docetaxel—Bullous eruption—Furosemide—dilated cardiomyopathy	0.00156	0.0176	CcSEcCtD
Docetaxel—Rash erythematous—Spironolactone—dilated cardiomyopathy	0.00148	0.0167	CcSEcCtD
Docetaxel—MAPT—heart—dilated cardiomyopathy	0.00147	0.0513	CbGeAlD
Docetaxel—MAP2—cardiac ventricle—dilated cardiomyopathy	0.00139	0.0484	CbGeAlD
Docetaxel—MAP2—myocardium—dilated cardiomyopathy	0.00131	0.0455	CbGeAlD
Docetaxel—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.00129	0.0146	CcSEcCtD
Docetaxel—Atrial flutter—Lisinopril—dilated cardiomyopathy	0.00122	0.0137	CcSEcCtD
Docetaxel—MAP4—heart—dilated cardiomyopathy	0.00116	0.0404	CbGeAlD
Docetaxel—Dysaesthesia—Lisinopril—dilated cardiomyopathy	0.00107	0.0121	CcSEcCtD
Docetaxel—BCL2—heart—dilated cardiomyopathy	0.00105	0.0367	CbGeAlD
Docetaxel—EGFR—heart—dilated cardiomyopathy	0.00104	0.0363	CbGeAlD
Docetaxel—Eruption—Furosemide—dilated cardiomyopathy	0.00101	0.0113	CcSEcCtD
Docetaxel—TUBB—cardiac ventricle—dilated cardiomyopathy	0.000982	0.0342	CbGeAlD
Docetaxel—TUBB2A—cardiac ventricle—dilated cardiomyopathy	0.000977	0.034	CbGeAlD
Docetaxel—TUBB6—cardiac ventricle—dilated cardiomyopathy	0.000964	0.0336	CbGeAlD
Docetaxel—TUBB—myocardium—dilated cardiomyopathy	0.000924	0.0322	CbGeAlD
Docetaxel—TUBB2A—myocardium—dilated cardiomyopathy	0.000919	0.032	CbGeAlD
Docetaxel—MAP2—heart—dilated cardiomyopathy	0.000912	0.0318	CbGeAlD
Docetaxel—TUBB6—myocardium—dilated cardiomyopathy	0.000906	0.0316	CbGeAlD
Docetaxel—ABCC10—cardiac ventricle—dilated cardiomyopathy	0.000844	0.0294	CbGeAlD
Docetaxel—Lethargy—Spironolactone—dilated cardiomyopathy	0.000842	0.00948	CcSEcCtD
Docetaxel—TUBB4B—cardiac ventricle—dilated cardiomyopathy	0.000838	0.0292	CbGeAlD
Docetaxel—TUBB4B—myocardium—dilated cardiomyopathy	0.000788	0.0275	CbGeAlD
Docetaxel—MAP2—cardiac atrium—dilated cardiomyopathy	0.00078	0.0272	CbGeAlD
Docetaxel—Ataxia—Spironolactone—dilated cardiomyopathy	0.000776	0.00874	CcSEcCtD
Docetaxel—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.000743	0.00837	CcSEcCtD
Docetaxel—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.000743	0.00837	CcSEcCtD
Docetaxel—TUBB4A—heart—dilated cardiomyopathy	0.000705	0.0246	CbGeAlD
Docetaxel—TUBB2B—heart—dilated cardiomyopathy	0.000681	0.0237	CbGeAlD
Docetaxel—Heartburn—Lisinopril—dilated cardiomyopathy	0.000674	0.00759	CcSEcCtD
Docetaxel—Drug interaction—Furosemide—dilated cardiomyopathy	0.000667	0.00751	CcSEcCtD
Docetaxel—Hearing impaired—Furosemide—dilated cardiomyopathy	0.00065	0.00732	CcSEcCtD
Docetaxel—TUBB—heart—dilated cardiomyopathy	0.000645	0.0225	CbGeAlD
Docetaxel—Throat sore—Lisinopril—dilated cardiomyopathy	0.000644	0.00725	CcSEcCtD
Docetaxel—TUBB2A—heart—dilated cardiomyopathy	0.000641	0.0223	CbGeAlD
Docetaxel—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.000638	0.00718	CcSEcCtD
Docetaxel—TUBB6—heart—dilated cardiomyopathy	0.000633	0.022	CbGeAlD
Docetaxel—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00063	0.0071	CcSEcCtD
Docetaxel—Renal failure—Spironolactone—dilated cardiomyopathy	0.000625	0.00704	CcSEcCtD
Docetaxel—Pleural effusion—Lisinopril—dilated cardiomyopathy	0.000606	0.00682	CcSEcCtD
Docetaxel—Otitis media—Lisinopril—dilated cardiomyopathy	0.000596	0.00671	CcSEcCtD
Docetaxel—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.000593	0.00668	CcSEcCtD
Docetaxel—TUBB2B—cardiac atrium—dilated cardiomyopathy	0.000583	0.0203	CbGeAlD
Docetaxel—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.000573	0.00645	CcSEcCtD
Docetaxel—ABCC1—myocardium—dilated cardiomyopathy	0.000561	0.0196	CbGeAlD
Docetaxel—ABCC10—heart—dilated cardiomyopathy	0.000554	0.0193	CbGeAlD
Docetaxel—Lightheadedness—Furosemide—dilated cardiomyopathy	0.000553	0.00623	CcSEcCtD
Docetaxel—TUBB—cardiac atrium—dilated cardiomyopathy	0.000552	0.0192	CbGeAlD
Docetaxel—TUBB4B—heart—dilated cardiomyopathy	0.00055	0.0192	CbGeAlD
Docetaxel—TUBB2A—cardiac atrium—dilated cardiomyopathy	0.000549	0.0191	CbGeAlD
Docetaxel—TUBB6—cardiac atrium—dilated cardiomyopathy	0.000541	0.0189	CbGeAlD
Docetaxel—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00054	0.00608	CcSEcCtD
Docetaxel—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.000524	0.00591	CcSEcCtD
Docetaxel—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.000519	0.00584	CcSEcCtD
Docetaxel—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.00051	0.00575	CcSEcCtD
Docetaxel—Swelling—Furosemide—dilated cardiomyopathy	0.000509	0.00573	CcSEcCtD
Docetaxel—Alopecia—Spironolactone—dilated cardiomyopathy	0.000504	0.00568	CcSEcCtD
Docetaxel—Oliguria—Lisinopril—dilated cardiomyopathy	0.000504	0.00567	CcSEcCtD
Docetaxel—Deafness—Furosemide—dilated cardiomyopathy	0.000502	0.00565	CcSEcCtD
Docetaxel—Drug interaction—Lisinopril—dilated cardiomyopathy	0.0005	0.00563	CcSEcCtD
Docetaxel—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000478	0.00538	CcSEcCtD
Docetaxel—ABCC10—cardiac atrium—dilated cardiomyopathy	0.000474	0.0165	CbGeAlD
Docetaxel—TUBB4B—cardiac atrium—dilated cardiomyopathy	0.00047	0.0164	CbGeAlD
Docetaxel—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00047	0.00529	CcSEcCtD
Docetaxel—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.000464	0.00523	CcSEcCtD
Docetaxel—Lethargy—Furosemide—dilated cardiomyopathy	0.000458	0.00516	CcSEcCtD
Docetaxel—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.000451	0.00508	CcSEcCtD
Docetaxel—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.000451	0.00507	CcSEcCtD
Docetaxel—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000445	0.00501	CcSEcCtD
Docetaxel—Fluid retention—Lisinopril—dilated cardiomyopathy	0.000441	0.00496	CcSEcCtD
Docetaxel—Neuropathy—Lisinopril—dilated cardiomyopathy	0.000436	0.00491	CcSEcCtD
Docetaxel—CYP1B1—heart—dilated cardiomyopathy	0.000436	0.0152	CbGeAlD
Docetaxel—Dehydration—Furosemide—dilated cardiomyopathy	0.000418	0.0047	CcSEcCtD
Docetaxel—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.000415	0.00467	CcSEcCtD
Docetaxel—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.000413	0.00465	CcSEcCtD
Docetaxel—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00041	0.00462	CcSEcCtD
Docetaxel—Confusional state—Spironolactone—dilated cardiomyopathy	0.000409	0.0046	CcSEcCtD
Docetaxel—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000406	0.00457	CcSEcCtD
Docetaxel—Cramp muscle—Furosemide—dilated cardiomyopathy	0.000404	0.00455	CcSEcCtD
Docetaxel—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.000404	0.00455	CcSEcCtD
Docetaxel—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000397	0.00447	CcSEcCtD
Docetaxel—ABCC1—heart—dilated cardiomyopathy	0.000392	0.0137	CbGeAlD
Docetaxel—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.000375	0.00422	CcSEcCtD
Docetaxel—Somnolence—Spironolactone—dilated cardiomyopathy	0.000361	0.00406	CcSEcCtD
Docetaxel—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.000355	0.004	CcSEcCtD
Docetaxel—Renal impairment—Lisinopril—dilated cardiomyopathy	0.000354	0.00399	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00035	0.00394	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000343	0.00386	CcSEcCtD
Docetaxel—Renal failure—Furosemide—dilated cardiomyopathy	0.00034	0.00383	CcSEcCtD
Docetaxel—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.000338	0.00381	CcSEcCtD
Docetaxel—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.000337	0.00379	CcSEcCtD
Docetaxel—ABCC1—cardiac atrium—dilated cardiomyopathy	0.000335	0.0117	CbGeAlD
Docetaxel—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000334	0.00376	CcSEcCtD
Docetaxel—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000327	0.00368	CcSEcCtD
Docetaxel—ABCG2—heart—dilated cardiomyopathy	0.000324	0.0113	CbGeAlD
Docetaxel—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000323	0.00364	CcSEcCtD
Docetaxel—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000321	0.00361	CcSEcCtD
Docetaxel—Ataxia—Lisinopril—dilated cardiomyopathy	0.000317	0.00357	CcSEcCtD
Docetaxel—Dehydration—Lisinopril—dilated cardiomyopathy	0.000313	0.00353	CcSEcCtD
Docetaxel—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000308	0.00346	CcSEcCtD
Docetaxel—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000307	0.00345	CcSEcCtD
Docetaxel—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000304	0.00343	CcSEcCtD
Docetaxel—Breast disorder—Lisinopril—dilated cardiomyopathy	0.000304	0.00343	CcSEcCtD
Docetaxel—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000303	0.00342	CcSEcCtD
Docetaxel—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000303	0.00342	CcSEcCtD
Docetaxel—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.000301	0.00339	CcSEcCtD
Docetaxel—Visual impairment—Furosemide—dilated cardiomyopathy	0.000299	0.00337	CcSEcCtD
Docetaxel—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000299	0.00336	CcSEcCtD
Docetaxel—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000294	0.00331	CcSEcCtD
Docetaxel—Eye disorder—Furosemide—dilated cardiomyopathy	0.00029	0.00327	CcSEcCtD
Docetaxel—Pruritus—Spironolactone—dilated cardiomyopathy	0.000287	0.00323	CcSEcCtD
Docetaxel—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000286	0.00322	CcSEcCtD
Docetaxel—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000284	0.00319	CcSEcCtD
Docetaxel—Angiopathy—Furosemide—dilated cardiomyopathy	0.000282	0.00317	CcSEcCtD
Docetaxel—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000281	0.00316	CcSEcCtD
Docetaxel—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000277	0.00312	CcSEcCtD
Docetaxel—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000277	0.00312	CcSEcCtD
Docetaxel—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000276	0.00311	CcSEcCtD
Docetaxel—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000272	0.00307	CcSEcCtD
Docetaxel—Erythema—Furosemide—dilated cardiomyopathy	0.00027	0.00304	CcSEcCtD
Docetaxel—Malnutrition—Furosemide—dilated cardiomyopathy	0.00027	0.00304	CcSEcCtD
Docetaxel—Dizziness—Spironolactone—dilated cardiomyopathy	0.000268	0.00302	CcSEcCtD
Docetaxel—Weight increased—Lisinopril—dilated cardiomyopathy	0.000265	0.00298	CcSEcCtD
Docetaxel—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000265	0.00298	CcSEcCtD
Docetaxel—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000263	0.00297	CcSEcCtD
Docetaxel—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000261	0.00294	CcSEcCtD
Docetaxel—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00026	0.00293	CcSEcCtD
Docetaxel—Vomiting—Spironolactone—dilated cardiomyopathy	0.000258	0.0029	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000257	0.0029	CcSEcCtD
Docetaxel—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000256	0.00288	CcSEcCtD
Docetaxel—Rash—Spironolactone—dilated cardiomyopathy	0.000256	0.00288	CcSEcCtD
Docetaxel—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000255	0.00288	CcSEcCtD
Docetaxel—Renal failure—Lisinopril—dilated cardiomyopathy	0.000255	0.00287	CcSEcCtD
Docetaxel—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000254	0.00287	CcSEcCtD
Docetaxel—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000254	0.00287	CcSEcCtD
Docetaxel—Headache—Spironolactone—dilated cardiomyopathy	0.000254	0.00286	CcSEcCtD
Docetaxel—Jaundice—Lisinopril—dilated cardiomyopathy	0.000253	0.00285	CcSEcCtD
Docetaxel—Anaemia—Furosemide—dilated cardiomyopathy	0.00025	0.00281	CcSEcCtD
Docetaxel—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000246	0.00276	CcSEcCtD
Docetaxel—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000245	0.00276	CcSEcCtD
Docetaxel—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000242	0.00273	CcSEcCtD
Docetaxel—Leukopenia—Furosemide—dilated cardiomyopathy	0.000242	0.00272	CcSEcCtD
Docetaxel—Nausea—Spironolactone—dilated cardiomyopathy	0.000241	0.00271	CcSEcCtD
Docetaxel—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000234	0.00263	CcSEcCtD
Docetaxel—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000233	0.00262	CcSEcCtD
Docetaxel—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000231	0.0026	CcSEcCtD
Docetaxel—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00023	0.00259	CcSEcCtD
Docetaxel—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00023	0.00258	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000229	0.00257	CcSEcCtD
Docetaxel—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000228	0.00257	CcSEcCtD
Docetaxel—Dry mouth—Furosemide—dilated cardiomyopathy	0.000225	0.00253	CcSEcCtD
Docetaxel—Confusional state—Furosemide—dilated cardiomyopathy	0.000222	0.00251	CcSEcCtD
Docetaxel—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000221	0.00248	CcSEcCtD
Docetaxel—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00022	0.00248	CcSEcCtD
Docetaxel—Shock—Furosemide—dilated cardiomyopathy	0.000217	0.00244	CcSEcCtD
Docetaxel—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000216	0.00244	CcSEcCtD
Docetaxel—Flushing—Lisinopril—dilated cardiomyopathy	0.000216	0.00244	CcSEcCtD
Docetaxel—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000216	0.00243	CcSEcCtD
Docetaxel—Skin disorder—Furosemide—dilated cardiomyopathy	0.000214	0.00241	CcSEcCtD
Docetaxel—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000211	0.00238	CcSEcCtD
Docetaxel—Anorexia—Furosemide—dilated cardiomyopathy	0.00021	0.00237	CcSEcCtD
Docetaxel—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00021	0.00236	CcSEcCtD
Docetaxel—Chills—Lisinopril—dilated cardiomyopathy	0.000209	0.00235	CcSEcCtD
Docetaxel—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000208	0.00234	CcSEcCtD
Docetaxel—Hypotension—Furosemide—dilated cardiomyopathy	0.000206	0.00232	CcSEcCtD
Docetaxel—Alopecia—Lisinopril—dilated cardiomyopathy	0.000206	0.00232	CcSEcCtD
Docetaxel—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000204	0.0023	CcSEcCtD
Docetaxel—Erythema—Lisinopril—dilated cardiomyopathy	0.000203	0.00228	CcSEcCtD
Docetaxel—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000203	0.00228	CcSEcCtD
Docetaxel—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000199	0.00224	CcSEcCtD
Docetaxel—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000198	0.00223	CcSEcCtD
Docetaxel—Back pain—Lisinopril—dilated cardiomyopathy	0.000196	0.00221	CcSEcCtD
Docetaxel—Somnolence—Furosemide—dilated cardiomyopathy	0.000196	0.00221	CcSEcCtD
Docetaxel—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000195	0.0022	CcSEcCtD
Docetaxel—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000192	0.00216	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00019	0.00214	CcSEcCtD
Docetaxel—Fatigue—Furosemide—dilated cardiomyopathy	0.00019	0.00214	CcSEcCtD
Docetaxel—Constipation—Furosemide—dilated cardiomyopathy	0.000189	0.00212	CcSEcCtD
Docetaxel—Pain—Furosemide—dilated cardiomyopathy	0.000189	0.00212	CcSEcCtD
Docetaxel—Anaemia—Lisinopril—dilated cardiomyopathy	0.000187	0.00211	CcSEcCtD
Docetaxel—Syncope—Lisinopril—dilated cardiomyopathy	0.000182	0.00205	CcSEcCtD
Docetaxel—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000182	0.00205	CcSEcCtD
Docetaxel—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000182	0.00204	CcSEcCtD
Docetaxel—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00018	0.00203	CcSEcCtD
Docetaxel—Palpitations—Lisinopril—dilated cardiomyopathy	0.000179	0.00202	CcSEcCtD
Docetaxel—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000178	0.00201	CcSEcCtD
Docetaxel—Cough—Lisinopril—dilated cardiomyopathy	0.000177	0.00199	CcSEcCtD
Docetaxel—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000174	0.00196	CcSEcCtD
Docetaxel—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000174	0.00196	CcSEcCtD
Docetaxel—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000173	0.00194	CcSEcCtD
Docetaxel—Chest pain—Lisinopril—dilated cardiomyopathy	0.000173	0.00194	CcSEcCtD
Docetaxel—Myalgia—Lisinopril—dilated cardiomyopathy	0.000173	0.00194	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000172	0.00193	CcSEcCtD
Docetaxel—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000169	0.0019	CcSEcCtD
Docetaxel—Confusional state—Lisinopril—dilated cardiomyopathy	0.000167	0.00188	CcSEcCtD
Docetaxel—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000166	0.00186	CcSEcCtD
Docetaxel—Oedema—Lisinopril—dilated cardiomyopathy	0.000166	0.00186	CcSEcCtD
Docetaxel—Infection—Lisinopril—dilated cardiomyopathy	0.000164	0.00185	CcSEcCtD
Docetaxel—Shock—Lisinopril—dilated cardiomyopathy	0.000163	0.00183	CcSEcCtD
Docetaxel—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000163	0.00183	CcSEcCtD
Docetaxel—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000162	0.00183	CcSEcCtD
Docetaxel—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000162	0.00182	CcSEcCtD
Docetaxel—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000161	0.00181	CcSEcCtD
Docetaxel—ABCB1—heart—dilated cardiomyopathy	0.00016	0.00557	CbGeAlD
Docetaxel—Asthenia—Furosemide—dilated cardiomyopathy	0.000158	0.00178	CcSEcCtD
Docetaxel—Anorexia—Lisinopril—dilated cardiomyopathy	0.000158	0.00178	CcSEcCtD
Docetaxel—Pruritus—Furosemide—dilated cardiomyopathy	0.000156	0.00176	CcSEcCtD
Docetaxel—Hypotension—Lisinopril—dilated cardiomyopathy	0.000155	0.00174	CcSEcCtD
Docetaxel—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000151	0.0017	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000151	0.0017	CcSEcCtD
Docetaxel—Insomnia—Lisinopril—dilated cardiomyopathy	0.00015	0.00169	CcSEcCtD
Docetaxel—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000149	0.00167	CcSEcCtD
Docetaxel—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000148	0.00166	CcSEcCtD
Docetaxel—Somnolence—Lisinopril—dilated cardiomyopathy	0.000147	0.00166	CcSEcCtD
Docetaxel—Dizziness—Furosemide—dilated cardiomyopathy	0.000146	0.00164	CcSEcCtD
Docetaxel—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000146	0.00164	CcSEcCtD
Docetaxel—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000144	0.00162	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000143	0.00161	CcSEcCtD
Docetaxel—Fatigue—Lisinopril—dilated cardiomyopathy	0.000143	0.00161	CcSEcCtD
Docetaxel—Pain—Lisinopril—dilated cardiomyopathy	0.000142	0.00159	CcSEcCtD
Docetaxel—Constipation—Lisinopril—dilated cardiomyopathy	0.000142	0.00159	CcSEcCtD
Docetaxel—Vomiting—Furosemide—dilated cardiomyopathy	0.00014	0.00158	CcSEcCtD
Docetaxel—Rash—Furosemide—dilated cardiomyopathy	0.000139	0.00157	CcSEcCtD
Docetaxel—Dermatitis—Furosemide—dilated cardiomyopathy	0.000139	0.00157	CcSEcCtD
Docetaxel—Headache—Furosemide—dilated cardiomyopathy	0.000138	0.00156	CcSEcCtD
Docetaxel—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000136	0.00154	CcSEcCtD
Docetaxel—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000135	0.00152	CcSEcCtD
Docetaxel—Nausea—Furosemide—dilated cardiomyopathy	0.000131	0.00148	CcSEcCtD
Docetaxel—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000131	0.00147	CcSEcCtD
Docetaxel—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000131	0.00147	CcSEcCtD
Docetaxel—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000122	0.00137	CcSEcCtD
Docetaxel—Asthenia—Lisinopril—dilated cardiomyopathy	0.000119	0.00134	CcSEcCtD
Docetaxel—Pruritus—Lisinopril—dilated cardiomyopathy	0.000117	0.00132	CcSEcCtD
Docetaxel—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000113	0.00128	CcSEcCtD
Docetaxel—Dizziness—Lisinopril—dilated cardiomyopathy	0.000109	0.00123	CcSEcCtD
Docetaxel—Vomiting—Lisinopril—dilated cardiomyopathy	0.000105	0.00119	CcSEcCtD
Docetaxel—Rash—Lisinopril—dilated cardiomyopathy	0.000104	0.00118	CcSEcCtD
Docetaxel—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000104	0.00117	CcSEcCtD
Docetaxel—Headache—Lisinopril—dilated cardiomyopathy	0.000104	0.00117	CcSEcCtD
Docetaxel—Nausea—Lisinopril—dilated cardiomyopathy	9.83e-05	0.00111	CcSEcCtD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	4.81e-05	0.0005	CbGpPWpGaD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	4.81e-05	0.0005	CbGpPWpGaD
Docetaxel—MAPT—MAPK Signaling Pathway—EGFR—dilated cardiomyopathy	4.8e-05	0.0005	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—AGT—dilated cardiomyopathy	4.79e-05	0.000499	CbGpPWpGaD
Docetaxel—ABCC1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.77e-05	0.000497	CbGpPWpGaD
Docetaxel—ABCC1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.77e-05	0.000497	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—LMNA—dilated cardiomyopathy	4.75e-05	0.000495	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.71e-05	0.000491	CbGpPWpGaD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	4.68e-05	0.000488	CbGpPWpGaD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	4.68e-05	0.000488	CbGpPWpGaD
Docetaxel—TUBB3—Metabolism of proteins—LMNA—dilated cardiomyopathy	4.66e-05	0.000485	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—NPPA—dilated cardiomyopathy	4.57e-05	0.000476	CbGpPWpGaD
Docetaxel—MAPT—MAPK Signaling Pathway—TNF—dilated cardiomyopathy	4.57e-05	0.000476	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—ANKRD1—dilated cardiomyopathy	4.56e-05	0.000475	CbGpPWpGaD
Docetaxel—EGFR—Direct p53 effectors—FAS—dilated cardiomyopathy	4.53e-05	0.000471	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways in Glioblastoma—RAF1—dilated cardiomyopathy	4.52e-05	0.00047	CbGpPWpGaD
Docetaxel—TUBB2A—Metabolism of proteins—LMNA—dilated cardiomyopathy	4.51e-05	0.00047	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—PSEN2—dilated cardiomyopathy	4.51e-05	0.00047	CbGpPWpGaD
Docetaxel—ABCC2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.49e-05	0.000467	CbGpPWpGaD
Docetaxel—ABCC1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.43e-05	0.000462	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—RAC1—dilated cardiomyopathy	4.41e-05	0.00046	CbGpPWpGaD
Docetaxel—TUBB1—Metabolism of proteins—LMNA—dilated cardiomyopathy	4.41e-05	0.000459	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—RPS6KB1—dilated cardiomyopathy	4.37e-05	0.000455	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—LMNA—dilated cardiomyopathy	4.35e-05	0.000452	CbGpPWpGaD
Docetaxel—MAPT—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	4.33e-05	0.000451	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—ITGB1—dilated cardiomyopathy	4.33e-05	0.00045	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	4.31e-05	0.000449	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—TAZ—dilated cardiomyopathy	4.29e-05	0.000446	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	4.28e-05	0.000445	CbGpPWpGaD
Docetaxel—EGFR—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	4.22e-05	0.00044	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.2e-05	0.000437	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.2e-05	0.000437	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	4.18e-05	0.000435	CbGpPWpGaD
Docetaxel—TUBB2B—Metabolism of proteins—ACE—dilated cardiomyopathy	4.16e-05	0.000433	CbGpPWpGaD
Docetaxel—TUBB6—Metabolism of proteins—ACE—dilated cardiomyopathy	4.16e-05	0.000433	CbGpPWpGaD
Docetaxel—MAPT—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	4.13e-05	0.000429	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—FASLG—dilated cardiomyopathy	4.06e-05	0.000423	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—EGFR—dilated cardiomyopathy	4.04e-05	0.000421	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	4.03e-05	0.000419	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.03e-05	0.000419	CbGpPWpGaD
Docetaxel—TUBB3—Metabolism of proteins—ACE—dilated cardiomyopathy	4.02e-05	0.000419	CbGpPWpGaD
Docetaxel—TUBB4A—Metabolism of proteins—LMNA—dilated cardiomyopathy	3.96e-05	0.000412	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—RAC1—dilated cardiomyopathy	3.95e-05	0.000411	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—FAS—dilated cardiomyopathy	3.91e-05	0.000407	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—RAC1—dilated cardiomyopathy	3.91e-05	0.000407	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	3.9e-05	0.000406	CbGpPWpGaD
Docetaxel—BCL2—Focal Adhesion—RAF1—dilated cardiomyopathy	3.9e-05	0.000406	CbGpPWpGaD
Docetaxel—TUBB2A—Metabolism of proteins—ACE—dilated cardiomyopathy	3.9e-05	0.000405	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	3.88e-05	0.000404	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—SDHA—dilated cardiomyopathy	3.88e-05	0.000403	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—RAC1—dilated cardiomyopathy	3.84e-05	0.000399	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.82e-05	0.000397	CbGpPWpGaD
Docetaxel—TUBB1—Metabolism of proteins—ACE—dilated cardiomyopathy	3.81e-05	0.000396	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	3.75e-05	0.00039	CbGpPWpGaD
Docetaxel—EGFR—ErbB1 downstream signaling—RAF1—dilated cardiomyopathy	3.71e-05	0.000386	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—RAC1—dilated cardiomyopathy	3.68e-05	0.000383	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—RAC1—dilated cardiomyopathy	3.68e-05	0.000383	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	3.66e-05	0.000381	CbGpPWpGaD
Docetaxel—TUBB4B—Metabolism of proteins—LMNA—dilated cardiomyopathy	3.62e-05	0.000377	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	3.61e-05	0.000376	CbGpPWpGaD
Docetaxel—KIF11—Immune System—RAF1—dilated cardiomyopathy	3.58e-05	0.000372	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	3.53e-05	0.000368	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—RAC1—dilated cardiomyopathy	3.48e-05	0.000362	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	3.46e-05	0.00036	CbGpPWpGaD
Docetaxel—TUBB4A—Metabolism of proteins—ACE—dilated cardiomyopathy	3.42e-05	0.000356	CbGpPWpGaD
Docetaxel—BCL2—Direct p53 effectors—EGFR—dilated cardiomyopathy	3.41e-05	0.000355	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.33e-05	0.000346	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.28e-05	0.000342	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ANKRD1—dilated cardiomyopathy	3.22e-05	0.000336	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—PSEN2—dilated cardiomyopathy	3.22e-05	0.000335	CbGpPWpGaD
Docetaxel—BCL2—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	3.21e-05	0.000335	CbGpPWpGaD
Docetaxel—ABCC10—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.19e-05	0.000332	CbGpPWpGaD
Docetaxel—TUBB4B—Metabolism of proteins—ACE—dilated cardiomyopathy	3.13e-05	0.000326	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ANKRD1—dilated cardiomyopathy	3.12e-05	0.000324	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—TAZ—dilated cardiomyopathy	3.03e-05	0.000315	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	3.01e-05	0.000313	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—TNF—dilated cardiomyopathy	3e-05	0.000312	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—RAC1—dilated cardiomyopathy	2.96e-05	0.000309	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—TAZ—dilated cardiomyopathy	2.93e-05	0.000305	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—RAF1—dilated cardiomyopathy	2.93e-05	0.000305	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ANKRD1—dilated cardiomyopathy	2.84e-05	0.000295	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—AGT—dilated cardiomyopathy	2.83e-05	0.000295	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—ITGB1—dilated cardiomyopathy	2.82e-05	0.000294	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ANKRD1—dilated cardiomyopathy	2.81e-05	0.000293	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—RAF1—dilated cardiomyopathy	2.8e-05	0.000292	CbGpPWpGaD
Docetaxel—EGFR—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	2.8e-05	0.000292	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—RAF1—dilated cardiomyopathy	2.76e-05	0.000287	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—SDHA—dilated cardiomyopathy	2.74e-05	0.000285	CbGpPWpGaD
Docetaxel—BCL2—Focal Adhesion—EGFR—dilated cardiomyopathy	2.67e-05	0.000278	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—TAZ—dilated cardiomyopathy	2.67e-05	0.000278	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	2.66e-05	0.000277	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—SDHA—dilated cardiomyopathy	2.65e-05	0.000276	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—TAZ—dilated cardiomyopathy	2.64e-05	0.000275	CbGpPWpGaD
Docetaxel—TUBB6—Metabolism of proteins—AGT—dilated cardiomyopathy	2.64e-05	0.000275	CbGpPWpGaD
Docetaxel—TUBB2B—Metabolism of proteins—AGT—dilated cardiomyopathy	2.64e-05	0.000275	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—RAF1—dilated cardiomyopathy	2.63e-05	0.000274	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—RAF1—dilated cardiomyopathy	2.62e-05	0.000273	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—RAF1—dilated cardiomyopathy	2.62e-05	0.000273	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—RAF1—dilated cardiomyopathy	2.61e-05	0.000271	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—RAF1—dilated cardiomyopathy	2.59e-05	0.00027	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CD36—dilated cardiomyopathy	2.57e-05	0.000267	CbGpPWpGaD
Docetaxel—TUBB3—Metabolism of proteins—AGT—dilated cardiomyopathy	2.55e-05	0.000265	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—RAF1—dilated cardiomyopathy	2.54e-05	0.000265	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	2.54e-05	0.000264	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—RAC1—dilated cardiomyopathy	2.51e-05	0.000261	CbGpPWpGaD
Docetaxel—TUBB2A—Metabolism of proteins—AGT—dilated cardiomyopathy	2.47e-05	0.000257	CbGpPWpGaD
Docetaxel—KIF11—Immune System—EGFR—dilated cardiomyopathy	2.45e-05	0.000255	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—RAF1—dilated cardiomyopathy	2.44e-05	0.000254	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—RAF1—dilated cardiomyopathy	2.44e-05	0.000254	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—RAF1—dilated cardiomyopathy	2.44e-05	0.000254	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—RAC1—dilated cardiomyopathy	2.42e-05	0.000252	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—RAF1—dilated cardiomyopathy	2.42e-05	0.000252	CbGpPWpGaD
Docetaxel—TUBB1—Metabolism of proteins—AGT—dilated cardiomyopathy	2.41e-05	0.000251	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—SDHA—dilated cardiomyopathy	2.41e-05	0.000251	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—RAF1—dilated cardiomyopathy	2.4e-05	0.00025	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—SDHA—dilated cardiomyopathy	2.39e-05	0.000249	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—RAF1—dilated cardiomyopathy	2.39e-05	0.000248	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.36e-05	0.000246	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	2.33e-05	0.000243	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—RAF1—dilated cardiomyopathy	2.31e-05	0.00024	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.3e-05	0.00024	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	2.3e-05	0.000239	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.28e-05	0.000238	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	2.27e-05	0.000236	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	2.27e-05	0.000236	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—RAC1—dilated cardiomyopathy	2.27e-05	0.000236	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—TNF—dilated cardiomyopathy	2.2e-05	0.000229	CbGpPWpGaD
Docetaxel—TUBB4A—Metabolism of proteins—AGT—dilated cardiomyopathy	2.17e-05	0.000226	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—RAF1—dilated cardiomyopathy	2.16e-05	0.000225	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.11e-05	0.00022	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	2.09e-05	0.000217	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.07e-05	0.000216	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	2.03e-05	0.000212	CbGpPWpGaD
Docetaxel—TUBB2B—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.02e-05	0.00021	CbGpPWpGaD
Docetaxel—TUBB6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.02e-05	0.00021	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—ITGB1—dilated cardiomyopathy	2.01e-05	0.00021	CbGpPWpGaD
Docetaxel—TUBB4B—Metabolism of proteins—AGT—dilated cardiomyopathy	1.98e-05	0.000206	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—RAF1—dilated cardiomyopathy	1.97e-05	0.000205	CbGpPWpGaD
Docetaxel—TUBB3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.95e-05	0.000203	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	1.91e-05	0.000199	CbGpPWpGaD
Docetaxel—TUBB2A—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.89e-05	0.000196	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	1.85e-05	0.000192	CbGpPWpGaD
Docetaxel—TUBB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.84e-05	0.000192	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	1.78e-05	0.000186	CbGpPWpGaD
Docetaxel—BCL2—Immune System—ITGB1—dilated cardiomyopathy	1.75e-05	0.000182	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	1.75e-05	0.000182	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	1.73e-05	0.00018	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—CD36—dilated cardiomyopathy	1.72e-05	0.000179	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—ITGB1—dilated cardiomyopathy	1.71e-05	0.000178	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NPPA—dilated cardiomyopathy	1.68e-05	0.000174	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.67e-05	0.000174	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—RAF1—dilated cardiomyopathy	1.66e-05	0.000173	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—TNF—dilated cardiomyopathy	1.66e-05	0.000173	CbGpPWpGaD
Docetaxel—TUBB4A—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.66e-05	0.000172	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.63e-05	0.000169	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PSEN2—dilated cardiomyopathy	1.62e-05	0.000169	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—RAC1—dilated cardiomyopathy	1.62e-05	0.000169	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.62e-05	0.000168	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—AGTR2—dilated cardiomyopathy	1.61e-05	0.000168	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CXCL2—dilated cardiomyopathy	1.61e-05	0.000168	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—RAF1—dilated cardiomyopathy	1.6e-05	0.000167	CbGpPWpGaD
Docetaxel—EGFR—Disease—NPPA—dilated cardiomyopathy	1.58e-05	0.000164	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.57e-05	0.000164	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	1.53e-05	0.00016	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	1.53e-05	0.00016	CbGpPWpGaD
Docetaxel—EGFR—Disease—PSEN2—dilated cardiomyopathy	1.53e-05	0.000159	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CD36—dilated cardiomyopathy	1.52e-05	0.000158	CbGpPWpGaD
Docetaxel—TUBB4B—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.51e-05	0.000158	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—RAF1—dilated cardiomyopathy	1.5e-05	0.000157	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.5e-05	0.000156	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CXCR3—dilated cardiomyopathy	1.5e-05	0.000156	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD36—dilated cardiomyopathy	1.49e-05	0.000156	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.47e-05	0.000153	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD36—dilated cardiomyopathy	1.46e-05	0.000152	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—ADRB1—dilated cardiomyopathy	1.45e-05	0.000151	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	1.44e-05	0.00015	CbGpPWpGaD
Docetaxel—SLC22A7—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.44e-05	0.00015	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—RAC1—dilated cardiomyopathy	1.43e-05	0.000149	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.42e-05	0.000148	CbGpPWpGaD
Docetaxel—BCL2—Immune System—RAC1—dilated cardiomyopathy	1.41e-05	0.000147	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—RAC1—dilated cardiomyopathy	1.37e-05	0.000143	CbGpPWpGaD
Docetaxel—SLCO1B3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.37e-05	0.000142	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—EGFR—dilated cardiomyopathy	1.35e-05	0.00014	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	1.3e-05	0.000136	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—AGTR1—dilated cardiomyopathy	1.24e-05	0.000129	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—ADRB2—dilated cardiomyopathy	1.17e-05	0.000122	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	1.16e-05	0.000121	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—EGFR—dilated cardiomyopathy	1.1e-05	0.000114	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—RAF1—dilated cardiomyopathy	1.07e-05	0.000112	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.07e-05	0.000111	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—GPX1—dilated cardiomyopathy	1.05e-05	0.00011	CbGpPWpGaD
Docetaxel—EGFR—Immune System—ITGB1—dilated cardiomyopathy	1.04e-05	0.000108	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—CD36—dilated cardiomyopathy	1.03e-05	0.000107	CbGpPWpGaD
Docetaxel—ABCC2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.79e-06	0.000102	CbGpPWpGaD
Docetaxel—ABCC1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.67e-06	0.000101	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CXCL2—dilated cardiomyopathy	9.51e-06	9.9e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AGTR2—dilated cardiomyopathy	9.51e-06	9.9e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—RAF1—dilated cardiomyopathy	9.48e-06	9.87e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	9.45e-06	9.83e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—RAF1—dilated cardiomyopathy	9.34e-06	9.72e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—AGT—dilated cardiomyopathy	9.23e-06	9.61e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—RAC1—dilated cardiomyopathy	9.12e-06	9.49e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—RAF1—dilated cardiomyopathy	9.11e-06	9.48e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	8.88e-06	9.25e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CXCR3—dilated cardiomyopathy	8.84e-06	9.2e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD36—dilated cardiomyopathy	8.84e-06	9.2e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—AGT—dilated cardiomyopathy	8.71e-06	9.07e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ADRB1—dilated cardiomyopathy	8.56e-06	8.91e-05	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	8.51e-06	8.86e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—RAC1—dilated cardiomyopathy	8.33e-06	8.67e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—RAC1—dilated cardiomyopathy	8.16e-06	8.49e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	8.03e-06	8.36e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	7.95e-06	8.27e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—RAC1—dilated cardiomyopathy	7.69e-06	8e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	7.57e-06	7.88e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—GPX1—dilated cardiomyopathy	7.44e-06	7.75e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.31e-06	7.61e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CD36—dilated cardiomyopathy	7.25e-06	7.55e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—GPX1—dilated cardiomyopathy	7.2e-06	7.5e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CD36—dilated cardiomyopathy	7.01e-06	7.3e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—TNF—dilated cardiomyopathy	7.01e-06	7.3e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.94e-06	7.22e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—GPX1—dilated cardiomyopathy	6.55e-06	6.82e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—AGT—dilated cardiomyopathy	6.53e-06	6.8e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—GPX1—dilated cardiomyopathy	6.49e-06	6.76e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—EGFR—dilated cardiomyopathy	6.41e-06	6.67e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CD36—dilated cardiomyopathy	6.38e-06	6.64e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CD36—dilated cardiomyopathy	6.32e-06	6.58e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—AGT—dilated cardiomyopathy	6.31e-06	6.57e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.04e-06	6.29e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.96e-06	6.2e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—AGT—dilated cardiomyopathy	5.74e-06	5.98e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—AGT—dilated cardiomyopathy	5.69e-06	5.93e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—RAF1—dilated cardiomyopathy	5.52e-06	5.75e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—RAF1—dilated cardiomyopathy	5.41e-06	5.63e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—RAC1—dilated cardiomyopathy	5.38e-06	5.61e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AGT—dilated cardiomyopathy	5.15e-06	5.36e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—RAF1—dilated cardiomyopathy	5.1e-06	5.31e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	4.69e-06	4.89e-05	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.6e-06	4.79e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	4.57e-06	4.76e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	4.12e-06	4.28e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—EGFR—dilated cardiomyopathy	3.71e-06	3.86e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—RAF1—dilated cardiomyopathy	3.57e-06	3.72e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	3.54e-06	3.69e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CD36—dilated cardiomyopathy	3.45e-06	3.59e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AGT—dilated cardiomyopathy	3.11e-06	3.23e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	2.18e-06	2.27e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	2.13e-06	2.21e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.91e-06	1.99e-05	CbGpPWpGaD
